Cutaquig Solution
Product Images NDC 0069-1802

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Cutaquig (NDC 0069-1802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

This text provides a formula for calculating the initial weekly dose of IGIV based on the previous IGIV dose in grams, multiplied by 1.30. The second line indicates that there is a variable for the number of weeks between IGIV doses, but it does not provide any further information or the formula for calculating that variable.*

FDA Label Image

Image File (Img0002)

FDA Label Image

Image File (Img0003)

FDA Label Image

Image File (Img0004)

FDA Label Image

Image File (Img0005)

FDA Label Image

Image File (Img0006)

FDA Label Image

Image File (Img0007)

FDA Label Image

Image File (Img0008)

FDA Label Image

Image File (Img0009)

FDA Label Image

Image File (Img0010)

FDA Label Image

Image File (Img0011)

This appears to be a table showing the In Vitro Reduction Factor for various production steps on different viruses including Non-Enveloped and Enveloped Viruses such as HIV-1, PRV, SBV, MEV and PPV. The methods tested include Ethanol fractionation, SID treatment, and pH4 treatment. The table shows the reduction factor for each virus type and method used.*

FDA Label Image

Image File (Img0012)

FDA Label Image

Image File (Img0013)

FDA Label Image

Image File (Img0014)

FDA Label Image

Image File (Img0015)

FDA Label Image

Image File (Img0016)

FDA Label Image

Image File (Img0017)

FDA Label Image

Image File (Img0018)

FDA Label Image

Image File (Img0019)

FDA Label Image

Image File (Img0020)

This is a description for a pharmaceutical product called "Cutaquig". It is an immune globulin solution meant for subcutaneous use only. It has a 6mL volume and should be stored at a temperature between +2° to +25°C. The product contains protein, maltose, polysorbate 80, and water for injections. One package insert is included for dosage and administration. The text also includes manufacturing information, an NDC (National Drug Code) number, and expiration date warnings.*

FDA Label Image

Image File (Img0021)

This is a description of Immune Globulin Subcutaneous medication called Cutaquig®. It is a solvent-detergent and pH treated medication that is to be used subcutaneously. The medication comes in 10mL vials and can be stored at temperatures between +2°C to +8°C or < +25°C for up to 9 months. The medication should be discarded if it is past the expiry date. The medication contains 165mg of Protan, 79mg of Maltose, and the solution is sterile and does not contain any preservatives. The package includes an insert for dosage and administration instructions.*

FDA Label Image

Image File (Img0022)

FDA Label Image

Image File (Img0023)

This is a description of a medication called "cutaquig®" which is a type of Immune Globulin Subcutaneous (Human) - hipp 16.5%. It is treated with SolventDetergent and pHd Treated and is available in a 20mL vial for subcutaneous use only. It can be stored at different temperatures depending on the duration of storage and can be stored at +25°C for up to 9 months without being refrigerated again during this period. The vial must be kept in the outer carton to protect it from light and should not be used after the expiry date. The medication is produced by ctapharma Phamazeutka Produrtonsgesm.bi. from Austria and contains 1 mL of solution with protein, matose, polysorbate, and water for injection. This medication is sterile and contains one preservative, and is suitable for dosage and administration.*

FDA Label Image

Image File (Img0024)

This is a description of 'Immune Globulin Subcutaneous' which comes in a 24 mL vial and is manufactured by Octapharma. It can be stored at +2°C to +8°C or room temperature for up to 9 months without being refrigerated again during this period but must be discarded if not used after that. It should not be used after the expiry date and the vial should be kept in the outer carton to protect it from light. Each 1 mL of solution contains 165 g of protein, of which 96% is human normal immunoglobulin G. It is important to consult the package insert for dosage and administration instructions.*

FDA Label Image

Image File (Img0025)

This is a description of a medication called Immune Globulin. It is used for subcutaneous use only and has a hipp 16.5% formulation containing 48 mL of solution. The medication is manufactured by Octapharma Phamazeut and is made in Austria. It is treated with SolventDetergent and PH4 and should be stored at +2°C to +8°C (36°F to 46%) for up to 36 months. It can be stored at up to +25°C (77°F) for up to 9 months without being refrigerated again during this period. The vial should be kept in the outer carton to protect it from light and should not be frozen. The medication contains protein, maltose, Polysorbate 80 and water for injection, but no preservatives. Dosage and administration instructions are in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.